A Astrup, 2000, Obes. Rev., 1, 57, 10.1046/j.1467-789x.2000.00013.x
LN Atopkina, 1999, Planta Med., 65, 30, 10.1055/s-1999-13957
AS Attele, 2002, Diabetes, 51, 1851, 10.2337/diabetes.51.6.1851
CX Bai, 2003, Eur. J. Pharmacol., 22, 35
D Bensky, 1993, Chinese Herbal Medicine Materia Medica
SH Chung, 2001, Arch. Pharm. Res., 24, 214, 10.1007/BF02978260
CH Choi, 2003, Planta Med., 69, 235, 10.1055/s-2003-38483
RB Duda, 2001, J. Korean Med. Sci., 16, S54, 10.3346/jkms.2001.16.S.S54
RB Duda, 1996, Ann. Surg. Oncol., 3, 515, 10.1007/BF02306082
RB Duda, 1999, J. Surg. Oncol., 72, 230, 10.1002/(SICI)1096-9098(199912)72:4<230::AID-JSO9>3.0.CO;2-2
EC Friedberg, 1986, Cancer Biology, 138
K Fujikawa-Yammamoto, 1987, Cancer J., 1, 349
J Fujimoto, 2001, Eur J. Gynaecol. Oncol., 22, 339
Fukushima SH, Wanibuchi H & Li W (2001) Inhibition by ginseng of colon carcinogenesis in rats. J. Korean Med. Sci. S75–S80.
Gillis CN, Kim HY, Chen X & Park H (1993) Pulmonary vascular effects of ginsenosides. Proceedings of 6th International Ginseng Symposium, pp. 36–39.
BH Han, 1982, Planta Med., 44, 146, 10.1055/s-2007-971425
H Hasegawa, 2000a, Microb. Ecol. Health Dis., 12, 85, 10.1080/089106000435473
H Hasegawa, 2000b, Biol. Pharm. Bull., 23, 298, 10.1248/bpb.23.298
H Hasegawa, 2000c, J. Trad. Med., 17, 186
H Hasegawa, 1996, Planta Med., 62, 453, 10.1055/s-2006-957938
H Hasegawa, 1995, Planta Med., 61, 409, 10.1055/s-2006-958126
H Hasegawa, 2002, Biol. Pharm. Bull., 25, 861, 10.1248/bpb.25.861
Hirai A (1999). Studies on the mechanisms of anti-platelet and anti-atherosclerotic effects of Korean red ginseng: Focusing on arachidonic acid cascade. Proceedings of ’99 Korea–Japan Ginseng Symposium, pp. 16–31.
KC Huang, 1999, The Pharmacology of Chinese Herbs
BH Jeon, 2000, Gen. Pharmacol., 35, 135, 10.1016/S0306-3623(01)00096-9
SY Kang, 1995, Life Sci., 56, 1577, 10.1016/0024-3205(95)00124-O
M Karikura, 1991a, Chem. Pharm. Bull. (Tokyo), 39, 400, 10.1248/cpb.39.400
M Karikura, 1991b, Chem. Pharm. Bull. (Tokyo), 39, 2357, 10.1248/cpb.39.2357
R Kasai, 1983, Chem. Pharm. Bull., 31, 2120, 10.1248/cpb.31.2120
Kim YS, Jin SH, Lee YH, Kim SI & Park JD (1999a) Ginsenoside Rh2 induces apoptosis independently of Bcl-2, Bcl-xL or Bax in C6Bu-1 cells. Proceedings of ’99 Korea–Japan Ginseng Symposium, pp. 150–162.
ND Kim, 1999b, Eur. J. Pharmacol., 367, 51, 10.1016/S0014-2999(98)00899-1
ND Kim, 1999c, Eur. J. Pharmacol., 367, 41, 10.1016/S0014-2999(98)00898-X
ND Kim, 1994, Gen. Pharmacol., 25, 1071, 10.1016/0306-3623(94)90121-X
YS Kim, 1998, Int. J. Biochem. Cell Biol., 30, 27, 10.1016/S1357-2725(97)00093-9
SW Kim, 2003, Biochem. Pharmacol., 65, 75, 10.1016/S0006-2952(02)01446-6
HS Kim, 2004, Arch. Pharm. Res., 27, 429, 10.1007/BF02980085
HE Kim, 1999d, Life Sci., 65, PL33
Kimura M (1980) Hypoglycemic component in ginseng radix and its insulin release. Proceedings of the 3rd International Ginseng Symposium. Korean Ginseng Research Institut, Seoul, Korea.
I Kimura, 1999, Phytother. Res., 13, 484, 10.1002/(SICI)1099-1573(199909)13:6<484::AID-PTR485>3.0.CO;2-X
M Kimura, 1981, J. Pharmacobiodyn., 4, 907, 10.1248/bpb1978.4.907
M Kimura, 1981a, J. Pharmacobiodyn., 4, 410, 10.1248/bpb1978.4.410
M Kimura, 1981b, J. Pharmacobiodyn., 4, 402, 10.1248/bpb1978.4.402
I Kitagawa, 1983, Yakugaku Zasshi, 103, 612, 10.1248/yakushi1947.103.6_612
K Kobashi, 1998, J. Trad. Med., 15, 1
K Kudo, 1998, Eur. J. Pharmacol., 341, 139, 10.1016/S0014-2999(97)01350-2
Kumar A (1993) Chemopreventive action of ginseng on DMBA-induced papillomagenesis in the skin of mice. Proc. 6th Intl. Ginseng Symp. (pp. 66–68).
SC Kuo, 1990, Planta Med., 56, 164, 10.1055/s-2006-960916
Lee KS (1980) Effect of ginseng saponin on the vascular smooth muscle. Proceedings of 3rd International Ginseng Symposium, pp. 71–76.
Lee YH, Kim SI, Lee SK, Chung HY & Kim KW(1993). Differentiation mechanism of ginsenosides in cultured murine F9 teratocarcinoma stem cells. Proceedings of 6th International Ginseng Symposium, pp. 127–131.
KY Lee, 1996, Cancer Lett., 110, 193, 10.1016/S0304-3835(96)04502-8
JY Lee, 2005, Carcinogenesis, 26, 359, 10.1093/carcin/bgh313
M Mochizuki, 1995, Biol. Pharm. Bull., 18, 1197, 10.1248/bpb.18.1197
H Nakata, 1998, Jpn. J. Cancer Res., 89, 733, 10.1111/j.1349-7006.1998.tb03278.x
T Odani, 1983, Chem. Pharm. Bull. (Tokyo), 31, 1059, 10.1248/cpb.31.1059
S Odashima, 1985, Cancer Res., 45, 2781
S Odashima, 1989, Gan To Kagaku Ryoho, 16, 1483
RM Palmer, 1988, Nature, 333, 664, 10.1038/333664a0
JD Park, 1996, Korean J. Ginseng Sci., 20, 389
Park JD, Baek NI, Lee YH, Kim DS, Park JH, Ryu JH & Kim SI (1998) Four new dammarane-glycosides, ginsenosides Rg5, Rh4, Rs3 and Rf2 from Korean red ginseng, the root of Panax ginseng C. A. Meyer. Proceedings of the 7th International Symposium on ginseng, pp. 115–126.
MT Park, 1999, Mol. Cells, 9, 476, 10.1016/S1016-8478(23)13573-4
JD Park, 1996, Arch. Pharm. Res., 19, 213, 10.1007/BF02976892
DG Popovich, 2002, Arch. Biochem. Biophys., 1, 1, 10.1016/S0003-9861(02)00398-3
DG Popovich, 2004, Can. J. Physiol. Pharmacol., 82, 183, 10.1139/y04-001
RM Rapoport, 1983, Circ. Res., 52, 352, 10.1161/01.RES.52.3.352
K Sato, 1994, Biol. Pharm. Bull., 17, 635, 10.1248/bpb.17.635
GI Scott, 2001, Br. J. Pharmacol, 134, 1159, 10.1038/sj.bjp.0704377
S Shibata, 2001, J. Korean Med., 16, S28, 10.3346/jkms.2001.16.S.S28
K Shinkai, 1996, Jpn. J. Cancer Res., 87, 357, 10.1111/j.1349-7006.1996.tb00230.x
S Shibata, 1963a, Chem. Pharm. Bull., 11, 759, 10.1248/cpb.11.759
S Shibata, 1963b, Chem. Pharm. Bull., 11, 762, 10.1248/cpb.11.762
Shibata S, Tanaka O, Shoji J & Saito H (1995) Chemistry and pharmacology of Panax. In: Economic and Medicinal Plant Research. Vol. 1. (pp. 217–284). Academic Press, New York.
U Sonnenborn, 1990, Zeitschrift fur phytotherapie, 11, 35
K Suda, 2000, J. Trad. Med., 17, 236
J Sung, 2000, Am. J. Chin. Med., 28, 205, 10.1142/S0192415X00000258
M Tatsuka, 2001, Jpn. J. Cancer Res., 92, 1184, 10.1111/j.1349-7006.2001.tb02138.x
CM Teng, 1989, Biochim. Biophys. Acta., 990, 315, 10.1016/S0304-4165(89)80051-0
CB Thompson, 1995, Science, 267, 1456, 10.1126/science.7878464
T Tode, 1993, Nippon Sanka Fujinka Gakkai Zasshi, 45, 1275
JR Vane, 1990, N. Engl. J. Med., 323, 27, 10.1056/NEJM199007053230106
V Vuksan, 2000, Arch. Intern. Med., 160, 1009, 10.1001/archinte.160.7.1009
C Wakabayashi, 1998, Biochem. Biophys. Res. Commun., 246, 725, 10.1006/bbrc.1998.8690
XG Wu, 2001, J. Korean Med., 16, S61, 10.3346/jkms.2001.16.S.S61
LJ Xia, 1996, Yao Xue Xue Bao, 31, 742
M Yammamoto, 1992, Ginseng Rev., 9, 15
T Yokozawa, 1985, Chem Pharm. Bull. (Tokyo), 33, 869, 10.1248/cpb.33.869
CS Yuan, 1999, Am. J. Chin. Med., 27, 331, 10.1142/S0192415X99000379
TK Yun, 2003, Mutat. Res., 523–524, 63, 10.1016/S0027-5107(02)00322-6
TK Yun, 2001, J. Korean Med., 16, S6, 10.3346/jkms.2001.16.S.S6
TK Yun, 1983, Cancer Detect. Prev., 6, 515
WJ Zhang, 1997, Cell Mol. Biol., 43, 581
W Zhou, 2004, Med. Sci. Monit., 10, RA187
